Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma
Brad S. Kahl, Opeyemi A. Jegede, Christopher Peterson, Lode J. Swinnen, Thomas M. Habermann, Stephen J. Schuster, Matthias Weiss, Paul A. Fishkin, Timothy S. Fenske, Michael E. Williams
Dive into the research topics of 'Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma'. Together they form a unique fingerprint.